Viridian TherapeuticsVRDN
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 170 institutions reported holding Viridian Therapeutics Inc. (VRDN) in their 13F filings, down 6 from Q1 2025. 20 opened new positions and 28 sold out. The largest holders were FMR LLC ($171.1M), BlackRock, Inc. ($77.2M) and Deep Track Capital, LP ($75.2M). 5 famous investors held it, including Lee Ainslie (0.5% of Maverick Capital's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Viridian Therapeutics Inc.
- CUSIP
- 92790C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 20 | $37.6M |
| Exits | 28 | $32.3M |
All 13F filers, Q1 2025 → Q2 2025: 9,708,922 shares bought and 6,526,788 shares sold, net +3,182,134 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 170 holders
| FMR LLC | 0.01% | Add +0.1% | 12,238,803 | $171.1M |
| BlackRock, Inc. | 0.00% | Reduce -3.3% | 5,521,035 | $77.2M |
| Deep Track Capital, LP | 2.42% | No change | 5,380,449 | $75.2M |
| Commodore Capital LP | 4.81% | Add +35.4% | 4,875,000 | $68.2M |
| Vanguard Group Inc. | 0.00% | Reduce -1.2% | 4,508,508 | $63.0M |
| Kynam Capital Management, LP | 6.66% | Reduce -5.8% | 4,427,927 | $61.9M |
| Venrock Adviser, LLC | 4.07% | No change | 3,882,709 | $54.3M |
| Fairmount Funds Management LLC | 6.27% | Add +0.4% | 3,459,913 | $48.4M |
| T. Rowe Price Associates Inc. | 0.00% | Add +71.5% | 2,895,265 | $40.5M |
| Tang Capital Management LLC | 2.01% | Add +1.8% | 2,842,925 | $39.7M |
| Paradigm Biocapital Advisors LP | 1.64% | Add +30.9% | 2,741,576 | $38.3M |
| State Street Corp. | 0.00% | Reduce -10.9% | 2,553,426 | $35.7M |
| Novo Holdings A/S | 2.35% | Add +5.8% | 2,380,000 | $33.3M |
| Maverick Capital | 0.48% | Add +9.5% | 2,257,010 | $31.6M |
| Alliancebernstein L.P. | 0.01% | Reduce -3.8% | 1,944,020 | $27.2M |
| Eversept Partners, LP | 2.68% | Add +38.1% | 1,902,539 | $26.6M |
| Baker Bros. Advisors LP | 0.24% | New | 1,744,406 | $24.4M |
| Geode Capital Management, LLC | 0.00% | Add +1.2% | 1,740,614 | $24.3M |
| Loomis Sayles & Co. L P | 0.02% | Reduce -2.3% | 1,338,472 | $18.7M |
| Parkman Healthcare Partners LLC | 2.10% | Add +22.0% | 1,298,825 | $18.2M |
| Pictet Asset Management Holding SA | 0.02% | Add +1.4% | 1,265,754 | $17.7M |
| Marshall Wace, LLP | 0.02% | Add +11.4% | 1,207,871 | $16.9M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | Reduce -0.5% | 1,108,586 | $15.5M |
| Vivo Capital, LLC | 1.41% | No change | 982,576 | $13.7M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -26.9% | 899,825 | $12.6M |
| Candriam S.C.A. | 0.07% | Reduce -2.1% | 862,273 | $12.1M |
| Woodline Partners LP | 0.06% | Add +0.2% | 815,485 | $11.4M |
| 5AM Venture Management, LLC | 3.96% | No change | 736,595 | $10.3M |
| Rosalind Advisors, Inc. | 4.74% | Add +17.6% | 700,000 | $9.8M |
| Citadel Advisors | 0.01% | Add +633.6% | 649,543 | $9.1M |
| Northern Trust Corp. | 0.00% | Reduce -15.0% | 596,883 | $8.3M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +1.4% | 574,021 | $8.0M |
| Victory Capital Management Inc. | 0.01% | Add +2.2% | 564,790 | $7.9M |
| UBS Group AG | 0.00% | Add +5.8% | 533,643 | $7.5M |
| Rice Hall James & Associates, LLC | 0.39% | Add +42.1% | 515,623 | $7.2M |
| Fisher Asset Management | 0.00% | Reduce -5.0% | 509,959 | $7.1M |
| Yiheng Capital Management, L.P. | 2.53% | No change | 500,261 | $7.0M |
| Dimensional Fund Advisors LP | 0.00% | New | 485,698 | $6.8M |
| HighVista Strategies LLC | 2.49% | Add +168.4% | 484,559 | $6.8M |
| Ikarian Capital, LLC | 2.17% | Reduce -5.0% | 469,949 | $6.6M |
| Perceptive Advisors LLC | 0.23% | Reduce -32.2% | 447,507 | $6.3M |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 0.70% | No change | 423,272 | $5.9M |
| JPMorgan Chase & Co. | 0.00% | Add +39.3% | 415,989 | $5.8M |
| Affinity Asset Advisors, LLC | 0.84% | No change | 390,000 | $5.5M |
| Deutsche Bank AG | 0.00% | Reduce -2.5% | 386,938 | $5.4M |
| Driehaus Capital Management LLC | 0.04% | Reduce -70.3% | 376,846 | $5.3M |
| Panagora Asset Management Inc. | 0.02% | Reduce -0.8% | 351,852 | $4.9M |
| Royal Bank of Canada | 0.00% | Add +162293.4% | 345,898 | $4.8M |
| Raymond James Financial Inc. | 0.00% | Add +4.3% | 332,089 | $4.6M |
| Wellington Management Group LLP | 0.00% | Add +8.6% | 270,543 | $3.8M |
| Barclays PLC | 0.00% | Add +86.3% | 231,104 | $3.2M |
| Bank of America Corp. | 0.00% | Add +28.2% | 230,844 | $3.2M |
| Nuveen, LLC | 0.00% | Reduce -10.2% | 223,235 | $3.1M |
| Principal Financial Group Inc. | 0.00% | Reduce -2.4% | 203,836 | $2.8M |
| Kopp Family Office, LLC | 1.84% | Reduce -1.1% | 203,230 | $2.8M |
| Morgan Stanley | 0.00% | Reduce -41.4% | 200,367 | $2.8M |
| Bank of New York Mellon Corp | 0.00% | Reduce -2.9% | 192,524 | $2.7M |
| BNP Paribas Financial Markets | 0.00% | Add +37.0% | 190,229 | $2.7M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +45.6% | 190,104 | $2.7M |
| Boothbay Fund Management, LLC | 0.08% | Add +25.6% | 182,452 | $2.6M |
| J. Safra Sarasin Holding AG | 0.04% | Add +135.5% | 171,119 | $2.4M |
| ADAR1 Capital Management, LLC | 0.39% | Add +116.0% | 170,598 | $2.4M |
| Hennion & Walsh Asset Management, Inc. | 0.10% | Reduce -15.5% | 168,324 | $2.4M |
| Macquarie Group Ltd. | 0.00% | Reduce -2.4% | 157,167 | $2.2M |
| Schonfeld Strategic Advisors LLC | 0.01% | Add +70.2% | 138,751 | $1.9M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.05% | Add +22.6% | 131,294 | $1.8M |
| Susquehanna International Group, LLP | 0.00% | Add +14.6% | 126,023 | $1.8M |
| Diadema Partners LP | 1.06% | Reduce -24.7% | 122,061 | $1.7M |
| Hudson Bay Capital Management LP | 0.01% | New | 119,562 | $1.7M |
| Susquehanna Fundamental Investments, LLC | 0.04% | Reduce -37.0% | 111,545 | $1.6M |
| Swiss National Bank | 0.00% | Add +1.3% | 108,900 | $1.5M |
| Rhumbline Advisers | 0.00% | Add +2.7% | 107,385 | $1.5M |
| American Century Companies Inc. | 0.00% | Reduce -14.9% | 104,567 | $1.5M |
| Point72 Asset Management | 0.00% | Reduce -49.2% | 104,043 | $1.5M |
| J. Goldman & Co LP | 0.04% | Reduce -15.0% | 100,777 | $1.4M |
| Vestal Point Capital, LP | 0.07% | New | 100,000 | $1.4M |
| Two Sigma Advisers, LP | 0.00% | Reduce -51.5% | 93,800 | $1.3M |
| Merck & Co., Inc. | 0.61% | No change | 93,414 | $1.3M |
| Knott David M Jr | 0.58% | Add +204.9% | 91,483 | $1.3M |
| TD Asset Management Inc | 0.00% | Add +174.8% | 89,600 | $1.3M |
| Moody Aldrich Partners LLC | 0.24% | Add +54.1% | 89,164 | $1.2M |
| Russell Investments Group, Ltd. | 0.00% | Reduce -55.7% | 87,885 | $1.2M |
| Velan Capital Investment Management LP | 1.21% | New | 86,500 | $1.2M |
| Wells Fargo & Company | 0.00% | Add +4.5% | 79,781 | $1.1M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +30.4% | 78,515 | $1.1M |
| Rafferty Asset Management, LLC | 0.00% | Reduce -27.8% | 76,412 | $1.1M |
| Two Sigma Investments, LP | 0.00% | Reduce -68.5% | 69,977 | $978K |
| Walleye Capital LLC | 0.01% | Reduce -37.9% | 64,556 | $902K |
| Invesco Ltd. | 0.00% | Add +30.2% | 62,217 | $870K |
| DCF Advisers, LLC | 0.42% | No change | 62,029 | $867K |
| Legal & General Group Plc | 0.00% | Reduce -0.4% | 59,983 | $839K |
| Millennium Management | 0.00% | Reduce -80.0% | 59,436 | $831K |
| Knights of Columbus Asset Advisors LLC | 0.05% | Reduce -2.1% | 58,024 | $811K |
| Graham Capital Management, L.P. | 0.02% | Add +203.6% | 55,196 | $772K |
| Verition Fund Management LLC | 0.00% | Add +205.8% | 53,925 | $754K |
| California State Teachers Retirement System | 0.00% | Reduce -1.9% | 53,689 | $751K |
| Susquehanna Portfolio Strategies, LLC | 0.02% | New | 52,571 | $735K |
| State of Wisconsin Investment Board | 0.00% | Add +15.8% | 51,425 | $719K |
| Intech Investment Management LLC | 0.01% | Reduce -17.8% | 50,668 | $708K |
| Alps Advisors Inc. | 0.00% | Reduce -28.5% | 43,969 | $615K |
"% of holder's portfolio" is VRDN's weight in each manager's 13F, not the share of Viridian Therapeutics Inc. the manager owns.